Cybin D/B/A Helus Pharma (HELP)

Healthcare · Biotechnology · NASDAQ

Cybin D/B/A Helus Pharma (HELP) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $1.00B and a free-cash-flow yield of -28.2%.

Market cap	$1.00B
Trailing P/E	—
FCF yield	-28.2%
Revenue growth (YoY)	—
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live HELP data on Nama Insights →